Clinical Trial Update: PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine. [Phase 4]

View source ↗

Summary

A Phase 4 trial at Stony Brook University is recruiting to assess the antidepressant effects of nicotine in Major Depressive Disorder using PET imaging with the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: Stony Brook University | Conditions: Major Depressive Disorder (MDD) | Phase 4 | Status: RECRUITING